Disease classification: a pitfall of the ERA/EDTA registry?

nomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 2005; 6: 691–699 18. Rossing K, Mischak H, Rossing P et al. The urinary proteome in diabetes and diabetes-associated complications: new ways to assess disease progression and evaluate therapy. Proteomics Clin Appl 2008; 2: 997–1007 19. Doucet A, Overall CM. Protease proteomics: revealing protease in vivo functions using systems biology approaches. Mol Aspects Med 2008; 29: 339–358 20. Olivieri F, Lorenzi M, Antonicelli R et al. Leukocyte telomere shortening in elderly type 2 DM patients with previous myocardial infarction. Atherosclerosis 2009; 206: 588–593 21. Carrero JJ, Stenvinkel P, Fellstrom B et al. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med 2008; 263: 302–312 22. Jiang H, Schiffer E, Song Z et al. Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease 1. Proc Natl Acad Sci U S A 2008; 105: 11299–11304 23. Wilson PW, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837–1847